Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NerdWallet A | NRDS | Nov 29, 2024 | 14.00 | -1.62 |
Nerdy A | NRDY | Nov 29, 2024 | 1.58 | +14.49 |
Net Lease Office Properties When Issued | NLOP | Nov 29, 2024 | 32.74 | +1.93 |
Net Power A | NPWR | Nov 29, 2024 | 12.81 | -1.39 |
NetApp | NTAP | Nov 29, 2024 | 122.64 | +0.17 |
Netcapital | NCPL | Nov 29, 2024 | 1.91 | +1.60 |
NetEase ADR | NTES | Nov 29, 2024 | 87.48 | +1.06 |
Netflix | NFLX | Nov 29, 2024 | 886.81 | +1.08 |
NETGEAR | NTGR | Nov 29, 2024 | 24.60 | +2.33 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 29, 2024 | 45.57 | +1.22 |
NetScout Systems | NTCT | Nov 29, 2024 | 21.88 | -0.64 |
NETSOL Technologies | NTWK | Nov 29, 2024 | 2.69 | +0.37 |
Netstreit | NTST | Nov 29, 2024 | 16.21 | -0.67 |
Network-1 Technologies | NTIP | Nov 29, 2024 | 1.37 | +2.24 |
Neuberger Berman | NML | Nov 29, 2024 | 9.44 | +1.40 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 29, 2024 | 7.82 | +0.77 |
Neuberger Berman Municipal Fund | NBH | Nov 29, 2024 | 10.90 | +0.18 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 29, 2024 | 13.18 | +0.38 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 29, 2024 | 3.90 | +0.78 |
NeueHealth | NEUE | Nov 29, 2024 | 5.05 | +5.80 |
Neumora Therapeutics | NMRA | Nov 29, 2024 | 9.94 | +1.84 |
Neuraxis | NRXS | Nov 29, 2024 | 2.97 | -4.10 |
Neurobo Pharmaceuticals | NRBO | Nov 29, 2024 | 2.36 | 0.00 |
Neurocrine Biosciences | NBIX | Nov 29, 2024 | 126.75 | +0.13 |
Neurogene | NGNE | Nov 29, 2024 | 25.43 | -1.43 |
NeuroMetrix | NURO | Nov 29, 2024 | 4.27 | -0.70 |
Neuronetics | STIM | Nov 29, 2024 | 1.00 | +3.83 |
NeuroOne | NMTC | Nov 29, 2024 | 0.62 | +0.45 |
Neuropace | NPCE | Nov 29, 2024 | 10.60 | +3.41 |
NeuroSense Therapeutics | NRSN | Nov 29, 2024 | 0.98 | +5.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.